多发性硬化患者中缓慢扩展病灶的患病率:系统综述与荟萃分析
该系统综述与荟萃分析纳入20项研究、4786例多发性硬化患者,评估缓慢扩展病灶(SEL)的患病率及其与顺磁性边缘病灶(PRL)的重叠情况。结果显示SEL占所有T2病灶的14%(95%CI 10-21),78%(67-85)的患者至少有一个SEL,11%(6-20)的SEL与PRL重叠。
要点
- SEL占所有T2病灶的14%(95%CI 10-21)。
- 78%(67-85)的多发性硬化患者至少有一个SEL。
- 11%(6-20)的SEL与PRL重叠,提示两种慢性活动性病灶标志物部分对应。
核心结论
- SEL虽仅占T2病灶的少数,但大多数多发性硬化患者至少有一个SEL,且部分SEL与PRL重叠,提示两种慢性炎症活动影像标志物存在部分对应。
研究设计与样本
- 系统检索PubMed、Scopus、Web of Science和Embase(截至2026年2月1日),纳入20项研究、4786例多发性硬化患者(平均年龄43.6±6.3岁,63.7%女性)。
主要发现
- SEL占所有T2病灶的14%(95%CI 10-21),78%(67-85)的患者至少有一个SEL。
- 敏感性分析后,每患者平均SEL体积为1.42 mL(95%CI 0.79-2.06),总T2病灶体积为10.6 mL(95%CI 8.53-12.67)。
- 11%(6-20)的SEL与PRL重叠。
- 亚组分析中,复发缓解型和进展型多发性硬化中SEL占T2病灶比例相似(15%),但进展型患者至少有一个SEL的比例更高。
临床怎么用
- 临床解读多发性硬化MRI时,可将SEL作为慢性活动性炎症的标志物之一,但需注意其与PRL仅部分重叠。
局限性
- 可能存在发表偏倚。
- 分析间异质性高且未发现显著来源。
- SEL识别方法存在差异。
- MRI时间点数量和时间安排存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Chronic active lesions (CALs) reflect chronic inflammation in multiple sclerosis (MS). Slowly expanding lesions (SELs) are CALs identified on conventional MRI by linear, concentric expansion over time, while paramagnetic rim lesions (PRLs) are CALs characterized by a paramagnetic rim on susceptibility-sensitive MRI. However, the prevalence of SELs and their overlap with PRLs remain unclear. The aims of this study were to (1) estimate the proportion of SELs among all T2 lesions and the proportion of patients with at least 1 SEL and (2) assess the proportion of SELs overlapping with PRLs. METHODS: We systematically searched PubMed, Scopus, Web of Science, and Embase on February 1, 2026, for studies evaluating SELs in MS. At least 2 authors independently assessed study eligibility. Primary outcomes were the pooled proportion of SELs among T2 lesions and the proportion of patients with at least 1 SEL. We estimated mean per-patient volumes of SELs and total T2 lesions and the proportion of SELs overlapping with PRLs. Random-effects generalized linear mixed-effects models and inverse-variance methods were used, with between-study heterogeneity assessed using τ2 and I2 and robustness using sensitivity analyses. Univariable meta-regression explored heterogeneity. PROSPERO: CRD42024603778. RESULTS: Of 5,980 records, 20 studies comprising 4,786 patients with MS were included (mean age: 43.6 ± 6.3 years; 63.7% female). Sample sizes varied by outcome. SELs accounted for 14% (95% CI 10-21) of all T2 lesions, and 78% (67-85) of patients had at least 1 SEL. After sensitivity analysis, per-patient mean volumes were 1.42 mL (0.79-2.06) for SELs and 10.6 mL (8.53-12.67) for total T2 lesions. In total, 11% (6-20) of SELs overlapped with PRLs. In subgroup analyses, proportions of SELs were similar in relapsing-remitting and progressive MS (15%), but the proportion of patients with at least 1 SEL was higher in progressive MS. Between-study heterogeneity was high across analyses with no significant sources identified. DISCUSSION: Although SELs represent a minority of T2 lesions, most patients have at least 1 SEL and a subset overlaps with PRLs, suggesting a partial correspondence between these 2 imaging markers of chronic inflammatory activity. Limitations include possible publication bias, high unexplained heterogeneity, differences in SEL identification methods, and differences in MRI time point number/timing.
引用
- Liampas A, Artemiadis A, Tseriotis VS, et al. Prevalence of Slowly Expanding Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis. Neurology. 2026. PMID: 42679340. doi:10.1212/WNL.0000000000218474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。